Utility of 18F-FDG-PET for detecting acute lymphoblastic leukemia: a case series of pediatric acute lymphoblastic leukemia without hematological symptoms

Int J Hematol. 2022 Feb;115(2):287-292. doi: 10.1007/s12185-021-03232-5. Epub 2021 Oct 13.

Abstract

Acute leukemia is typically diagnosed from presenting features related to hematological symptoms, but certain patients present with prominent musculoskeletal pain without signs of hematological abnormality. We reviewed the medical records of 58 children diagnosed with acute lymphoblastic leukemia (ALL) at our hospital to evaluate initial features. Forty six of these patients had hematological symptoms, anemia, or hemorrhage (Group H), while 12 patients had prominent musculoskeletal pain without hematological symptoms (Group P). Diagnosis of leukemia took significantly more time for those 12 patients (Group H, 17.1 days; Group P, 48.5 days). In three of the 12 patients in Group P, localized abnormal imaging findings and unremarkable blood test results led to initial diagnoses of chronic recurrent multifocal osteomyelitis, bone fracture, and septic osteomyelitis. However, 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) revealed multiple intense bone foci or systemic bone marrow uptake, leading to the diagnosis of ALL. A review of 18F-FDG-PET results from 23 patients with ALL who underwent a PET scan (Group H, n = 15; Group P, n = 8) showed multiple bone foci or systemic bone marrow uptake in all cases. In conclusion, lack of hematological symptoms in ALL patients can delay diagnosis, and 18F-FDG-PET is useful for diagnosing leukemia in such cases.

Keywords: 18F-FDG-PET; ALL; Musculoskeletal pain.

MeSH terms

  • Bone and Bones / diagnostic imaging
  • Child
  • Child, Preschool
  • Female
  • Fluorodeoxyglucose F18 / analysis
  • Humans
  • Male
  • Positron-Emission Tomography* / methods
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnostic imaging*
  • Radiopharmaceuticals / analysis

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18